Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Reports Increased Revenues, Earnings in Q2

NEW YORK, July 23 (GenomeWeb News) - Molecular Devices yesterday reported increased revenues and earnings for the second quarter.


Revenues totaled $32.2 million, up from $28.5 million during the same quarter last year.


R&D expenses stayed flat at $4.7 million, compared to $4.8 million during the same period a year ago.


The company's net income for the quarter was $2.5 million, or $.17 per share, up from $1.8 million, or $.12 per share, during the same period in 2003.


As of June 30, the company had $54.2 million in cash and cash equivalents.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.